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Chicken Toll-like Receptor 3 Recognizes Its Cognate Ligand 
When Ectopically Expressed in Human Cells 
HEIKE SCHWARZ, 1 KIRSTEN SCHNEIDER, 1 ANNETTE OHNEMUS, 1 MIHA LAVRIC, 2 
SONJA KOTHLOW, 2 STEFAN BAUER, 3 BERND KASPERS,2 and PETER STAEHELI 1 
A B S T R A C T 
Recognition of pathogens by toll-like receptors (TLRs) causes activation of signaling cascades that trigger cy-
tokine secretion and, ultimately, innate immunity. Genes encoding proteins with substantial homology to mam-
malian T L R 1 , T L R 2 , T L R 3 , T L R 4 , T L R 5 , and T L R 7 are present in the chicken genome, whereas orthologs 
of T L R 8 , T L R 9 , and TLR10 seem to be defective or missing. Except for chicken T L R 2 (ChTLR2), which was 
previously shown to recognize lipopeptides and lipopolysaccharides (LPS), the ligand specificity of ChTLRs 
had not been determined. We found that polyI:C, LPS , R848, S-28463, and ODN2006, which are specifically 
recognized by T L R 3 , T L R 4 , TLR7/8, and T L R 9 in mammals, induced substantial amounts of type I inter-
feron (IFN) and interleukin-6 (IL-6) in freshly prepared chicken splenocytes. To determine the ligand speci-
ficity of C h T L R 3 and C h T L R 7 , we used a standard reporter assay frequently employed for analysis of mam-
malian T L R s . Neither S-28463 nor any other T L R ligand induced reporter activity in human 293 cells 
expressing ChTLR7. However, human 293 cells expressing C h T L R 3 strongly and specifically responded to 
polyLC, demonstrating that this chicken receptor represents a true ortholog of mammalian T L R 3 . 
INTRODUCTION 
TH E T O L L - L I K E R E C E P T O R (TLR) multigene family codes for important recognition receptors of the innate immune sys-
tem. In humans and other mammals, 10 or more TLRs with 
mostly distinct ligand specificity have been recognized.1-2 The 
chicken genome contains genes with homology to T L R L TLR2, 
TLR3, TLR4, TLR5, and TLR7. 3 7 Furthermore, a novel TLR 
gene, TLR 15, identified in chickens, is upregulated in response 
to heat-lkilled Salmonella enterica but shows no decisive simi-
larity to the extracellular domain of any known mammalian 
TLR. 8 Interestingly, chickens appear to lack an ortholog of 
TLR9, 4 although chicken macrophages and peripheral blood 
mononuclear cells (PBMCs) can respond to CpG oligonu-
cleotides.9 In light of these differences and peculiarities of the 
chicken TLR system, it is important to know i f the various 
chicken TLR orthologs have the same ligand specificities as 
their mammalian counterparts. 
Chicken TLR2 (ChTLR2) was shown to act as a receptor for 
bacterial lipoprotein and, similar to studies of human TLR2 
(HuTLR2), was demonstrated to recognize lipopolysaccharide 
(LPS) im the presence of MD2. 3 Genetic evidence suggests that 
ChTRL4 plays a role in resistance to Salmonella infections,1 0 
suggesting that it has a function similar to that of TLR4 of mam-
mals. For other ChTLRs, the ligand specificity has not been de-
termined experimentally. We show here that cultured chicken 
spleen cells readily respond to TLR ligands that activate TLR3, 
TLR4, TLR7/8, and TLR9 in mammals. By analyzing the re-
sponse to various TLR ligands of transfected human 293 cells 
expressing full-length cDNAs for ChTLR3 and C1VTLR7, we 
demonstrate that double-stranded RNA (dsRNA) is specifically 
recognized by ChTLR3. Imidazoquinolines, such as R848 or S-
28463, and CpG oligonucleotides failed to activate transfected 
293 cells expressing either ChTLR3, ChTLR7, or both, leaving 
the identity of the chicken receptors recognizing these TLR l i -
gands undefined. 
M A T E R I A L S AND METHODS 
Spleen cell cultures 
Spleens from adult White Leghorn chickens were dissoci-
ated mechanically using stainless steal sieves, washed with 
'Department of Virology, University of Freiburg, 79104 Freiburg. Germany. 
2Instittute for Animal Physiology, University of Munich, Munich, Germany. 
3Institxute for Medical Microbiology. Hygiene and Immunology. TU Munich, Munich, Germany. 
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phosphate-buffered saline (PBS), suspended in RPMI medium 
containing 1.0% fetal bovine serum (FBS), and seeded into 48-
well culture plates. TLR ligands were added to the culture 
medium at the indicated concentrations for 24 h. 
TLR ligands 
Ultrapure LPS, polyI:C, ODN2006, R848, and purified DNA 
from Escherichia coli were purchased from InvivoGen (San 
Diego, CA). S-28463 was a gift from Dr. M . Tomai (3M Phar­
maceutical, St. Paul, MN). 
Cytokine assays 
Quail CEC32 cells stably transfected with a chicken Mx pro­
moter-lucif erase reporter construct were used for titrating type 
I interferon (IFN) as described.11 Interleukin-6 (IL-6) activity 
was determined using the IL-6-dependent mouse Β cell line 
7TD1 as described.12 
Expression plasmids 
To construct the ChTLR3 expression plasmid, two PCR frag­
ments representing the 5' and 3' halves of ChTLR3 cDNA, re­
spectively, were cloned between the NotI and Nhel restriction 
sites of plasmid pCA. 1 3 cDNAs were amplified by doing semi-
nested PCR on cDNA derived from bronchial-associated lung 
tissue. For amplification of the 5' fragment, forward primer 5'-
AAATGCGGCCGCTATGGGATGCTCTATTCCTTGC-3' 
and reverse primer 5' -CC AG ATTATTGC A ACCTACC-3' were 
used in a first PCR. A second PCR was done using the same for­
ward primer and reverse primer 5'-CCTTCGAATTCATGAC-
CTGTG-3'. For amplification of the 3' fragment of ChTLR3 
cDNA, forward primer 5' -TGTAC AGC A ACC A A ATC AC-3' 
and reverse primer 5' -GAGAGCTAGCTCAGCGCACTTTAC-
TATTAG-3' were used for the first PCR. A second PCR was 
done using the forward primer 5'-GGTC ATG A ATTCG A AG-
GTCTC-3' and the same reverse primer. The sequence of our 
ChTLR3 clone was deposited at GenBank under accession num­
ber DQ780341. 
To construct expression plasmid ChTLR7-long, PCR was 
performed on EST clone rikenl-19dl0ii using forward primer 
5' -GAGAGCGGCCGCTATG AC A A ATCTTTC AG AGG-3' 
and reverse primer 5' -G AG AGCT AGCCT A A AC AGTTTC-
CTGGAGAAG-3', and the resulting product was cloned be­
tween the NotI and Nhel restriction sites of the pCA vector. To 
generate expression plasmid ChTLR7-short, PCR was per­
formed using the same reverse primer and forward primer 5'-
G AG AGCGGCCGCT ATGGT AC ATC ATGCC A AGG-3', and 
the 5'-truncated product was cloned into the same restriction 
sites of the pCA vector. The sequences of our ChTLR7-long 
and ChTLR7-short were deposited at GenBank under accession 
number DQ780342. Expression plasmids for HuTLR7 1 4 and 
HuTLR9 (InvivoGen) and NF-KB-luciferase reporter construct 
p55A2Luc 1 5 were described previously. 
TLR activity assay 
HEK293 cells in 6-well plates were transfected with 250 ng 
of reporter plasmid p55A2Luc and 1 ^ g of the various TLR ex­
pression plasmids using Metafectene (Biontex, Munich, Ger­
many). About 15 h posttransfection, the cells were removed 
from the culture plates using trypsin and seeded into 24-well 
dishes. Some 9 h later, the cells were treated with TLR ligands 
for 15 h. The cells were then lysed in 100 μΧ, of lysis buffer 
(Promega, Madison, WI) , and the luciferase activity in 10 -μ ί 
samples was determined in a Berthold LB9010 luminometer us­
ing 50 μ Τ of luciferase substrate (Promega). 
R E S U L T S 
Chicken spleen cells readily respond to 
various TLR ligands 
To determine the extent of the TLR response in chickens, 
we stimulated cultures of freshly explanted spleen cells with ei­
ther polyI:C, LPS, R848, or ODN2006. Culture supernatants 
were harvested at 24 h postStimulation and assayed for the pres­
ence of type I IFN and IL-6 using appropriate bioassays. Su­
pernatants of unstimulated spleen cells did not contain de­
tectable levels of cytokine activity, whereas supernatants of 
F I G . 1. Chicken spleen cells readily respond to TLR ligands. 
Triplicate cultures of freshly explanted chicken spleen cells
were stimulated for 24 h with either polyLC (25 ng/mL), LPS 
(10 Mg/mL), R848 (1 Mg/mL), or ODN2006 (1 μΜ), as indi­
cated. Splenocyte supernatants were then analyzed for the pres­
ence of (A) type I IFN using the CEC32-511 indicator cell line, 
which carries an Mx promoter-controlled luciferase reporter
gene, or (B) IL-6 by measuring IL-6-dependent proliferation of
the murine hybridoma cell line 7TD1. Average values are
shown. Variation between the triplicates was minimal. 






chTLR3 •OiNiHiil i^ll 
S S LRRCT TM 
MTNLSEVAAHRKMVHHARTSNALLFVLLFLFPMLLSG (chTLR7-long) 
M V H H A R T S N A L L F V L L F L F P M L L S G (chTLR7-short) 
F I G . 2. Domain structures of ChTLR3 and ChTLR7. Domains of the mature protein were identified using the SMART soft­
ware package. The signal sequence of ChTLR3 was determined using the SignalP3.0 program. SS, signal sequence; LRR, leucine-
rich repeat; TM, transmembrane domain; TIR, TIR domain; LRRNT, cysteine-rich region flanking LRR domain at the N-termi-
nus; LRRCT, cysteine-rich region flanking the LRR domain at the C-terminus. Arrows mark differences from published amino 
acid sequences of ChTLR3 and ChTLR7 (accession numbers AY633575 and AY633577). Two different signal sequences found 
in ChTLR7 resulting from putative translation initiation of the mRNA at two different AUG codons are shown in single amino 
acid code. 
cells treated with TLR ligands contained substantial amounts 
of both IFN and IL-6 (Fig. 1). None of the TLR ligands induced 
luciferase activity when added directly to the indicator cells 
(data not shown), excluding possible artifacts of the assay sys­
tem. In several independent experiments, ODN2006 was a po­
tent inducer of IL-6 and IFN activity. LPS and R848 induced 
high amounts of IL-6 but lower levels of IFN. Cytokine in­
duction by polyhC was comparably weak. IFN and IL-6 activ­
ity was also detected in supernatants of spleen cells treated with 
S-28463 or purified DNA from E. coli (data not shown). Col­
lectively, these results demonstrated that chicken immune cells 
are equipped with receptors that recognize ligands that specif­
ically activate TLR3, TLR4, TLR7/8, and TLR9 in mammals. 
Full-length cDNAs encoding ChTLR3 and ChTLR7 
ChTLRs with high homology to mammalian TLR3 and 
TLR7 were identified previously.4-6 Full-length cDNAs for 
these two molecules used in our laboratory showed several nu­
cleotide differences compared with database entries AY633575 
and AY633577, resulting in the amino acid changes indicated 
in Figure 2. It should be noted that our cDNA clone for ChTLR7 
contains additional nucleotides at the 5' end that extend the 
open reading frame (ORF) at the N-terminus compared with 
another EST clone.6 Consequently, the putative full-length 
translation product of our cDNA clone (designated ChTLR7-
long) contains a signal sequence that is 12 amino acids longer 
than the signal sequence in the previously described molecule6 
(designed as ChTLR7-short). 
Ligand specificity of ChTLR3 and ChTLR7 
To determine the ligand specificity of ChTLR3 and ChTLR7, 
we employed a reporter assay system frequently used for anal­
ysis of mammalian TLRs. HEK293 cells were transfected with 
an NF-κΒ-luciferase reporter construct and expression plasmids 
for TLRs. At 24 h posttransfection, the cells were stimulated 
for 15 h with TLR ligands before measurement of luciferase 
activity in the cell lysates. Under these experimental conditions, 
ChTLR3 conferred a high degree of responsiveness to polyLC 
but not LPS, S-28463, and ODN2006 (Fig. 3A), demonstrating 
identical TLR specificities of chicken and human TLR3. When 
expressed in HEK293 cells, neither the long nor the short form 
of ChTLR7 mediated a response to S-28463 (Fig. 3B). 
HuTLR7, which served as positive control in these transfec-
tions, was active, indicated by the fact that transfected HEK293 
cells readily responded to S-28463. None of the other TLR l i ­
gands used for these experiments, including polyLC, LPS, 
R848, and ODN2006, was recognized by HEK293 cells ex­
pressing ChTLR7 (Fig. 3B; data not shown). 
To evaluate the remote possibility that ChTLR7 might rec­
ognize its ligands only if complexed with TLR3 and to deter­
mine i f heterodimers of ChTLR3 and ChTLR7 might recognize 
unmethylated dsDNA, the two cDNAs were coexpressed in 
HEK293 cells. Expression of ChTLR7 had no negative effect 
on TLR3 activity, but it did not induce the formation of het-
erodimeric complexes with specificity for S-28463 or 
ODN2006 (Fig. 3C). HuTLR9, which served as positive con­
trol for this experiment, conferred responsiveness to ODN2006 
and, to a lesser extent, to polyLC (Fig. 3C). 
DISCUSSION 
Available genetic information indicates that chickens lack 
functional orthologs of mammalian TLR8, TLR9, and TLR10 4 
but instead possess at least one TLR gene (TLR 15) with no ob­
vious counterpart in mammals.8 This constellation raises the 
question whether chicken cells are capable of responding to 
TLR agonists known to be active in mammals and whether cer­
tain ChTLRs might have unexpected ligand specificities. Our 
studies with freshly explanted spleen cells revealed that the 
chicken has no obvious deficits in recognition of pathogen-as-
100 S C H W A R Z E T A L . 
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C 
m c h T L R 3 + chTLR7- long 
F I G . 3. ChTLR3 confers responsiveness of human cells to 
polyI:C. HEK293 cells were transfected with an N F - K B - I U C I I -
erase reporter construct and expression plasm ids for either (A) 
ChTLR3, (B) short or long version of ChTLR7, and (C) 
ChTLR3 and ChTLR7. Expression plasmids encoding HuTLR7 
and HuTLR9 served as positive controls. At 24 h posttransfec-
tion, the cells were stimulated for 15 h with either polyLC (25 
ng/mL), LPS (10 Mg/mL), S-28463 (1 Mg/mL), or ODN2006 
( I μ,Μ). TLR-mediated activation of N F - K B was assessed by 
measuring luciferase activity in the cell lysates. 
sociated molecular patterns. We found that ligands expected to 
be recognized by TLR3, TLR4, TLR7/8, and TLR9 readily in­
duced the synthesis of type I IFN and IL-6. These results con­
firm and extend earlier studies that showed that IFN-α genes 
are activated in the spleen of chickens after oral treatment with 
S-2846316 and that chicken heterophils are responding to CpG 
oligonucleotides.9 
Responsiveness to a broad panel of TLR agonists in the ab­
sence of certain TLR orthologs inevitably leads to the hypoth­
esis that certain TLRs of the chicken might exhibit broader l i ­
gand specificity than their mammalian counterparts. A simple 
way to analyze ligand specificity of ChTLRs is to employ well-
established technology that was successfully used to decipher 
the specificity of mammalian TLRs. A potential limitation of 
this approach is that ChTLRs might not reveal their activity be­
cause of the lack of species-specific accessory factors that are 
not present in human cells. However, prior to our work, it was 
demonstrated that ChTLR2 is functional when expressed in the 
human HEK293 cell line. 3 Our own experiments unambigu­
ously showed that ChTLR3 is active in HEK293 cells and that 
it exclusively recognizes dsRNA, like its mammalian counter­
part. 
The experimental approach with HEK293 cells failed to 
show the ligand specificity of ChTLR7. We evaluated the pos­
sibility that two putative ChTLR7 variants with long and short 
leader peptides might exhibit different activities, but both forms 
of ChTLR7 yielded negative results in this assay. We further 
evaluated the possibility that ChTLR7 might recognize variant 
imidazoquinolines with different efficacy. However, neither S-
28643 nor R848 was recognized by HEK293 cells expressing 
ChTLR7. We also examined if polyLC or unmethylated DNA, 
such as ODN2006, would activate HEK293 cells expressing 
ChTLR7. A l l these attempts failed to yield evidence for 
ChTLR7 activation by known TLR ligands. Coexpression of 
ChTLR3 and ChTLR7 similarly failed to induce heterodimeric 
forms that would have recognized imidazoquinolines or un­
methylated DNA. Thus, at least two possibilities remain that 
might explain our findings. First, it is possible that our cDNA 
clone, which differs from the published ChTLR7 sequence by 
six amino acid changes, represents an inactive molecule. Sec­
ond, ChTLR7 may require an unknown accessory factor that is 
not present in human HEK293 cells. 
From our work, it is clear that the chicken ortholog of mam­
malian TLR3 specifically recognizes polyLC, like its mam­
malian counterpart. However, the ligand specificity of the 
chicken ortholog of TLR7 remains undefined. Further studies 
are needed to determine i f ChTLR7 can mediate the responses 
of chicken cells to such ligands as R848 and S-28463. It re­
mains unclear i f ChTLR7 is involved in recognition of un­
methylated DNA, like ODN2006, or i f the recently discovered 
unique TLR of chickens might play a role in the recognition of 
unmethylated DNA in chickens.8 
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